gC1q Fragment Isolation Protocol

For more than a decade, Creative Biolabs has been dedicated to providing professional, tailored customer service and has earned a global reputation for providing outstanding customer assistance to a wide range of clients. We have unique R&D expertise to provide the highest quality customized services and a range of complement-related products at different sizes and affordable prices within the complement industry. Here, we provide a gC1q fragment isolation protocol flow chart to provide easily accessible information reference for clients' experiments, hoping to effectively shorten your project cycle and promote research.

gC1q Fragment Isolation Protocol

The gC1q fragment can be obtained by collagenase digestion of the collagen-like fragment of purified C1q. The collagenase and undigested C1q is removed from the incubation mixture by size-exclusion chromatography.

Flow chart of isolation of the CLR of C1q by Pepsin Digestion. (Creative Biolabs)

Fig.1 Flow chart of gC1q fragment isolation protocol by collagenase digestion. (Creative Biolabs)

Published Data

Identification of the possible NE cleavage site on gC1q. Fig.2 Mapping of potential neutrophil elastase cleavage sites on gC1q.1

To experimentally pinpoint the exact cleavage sites, a mutagenesis analysis was employed. Initially, the main products from neutrophil elastase (NE) digestion of gC1q, with apparent molecular weights between 12 and 17 kDa, were gel-purified and analyzed using MALDI-TOF. Two primary peaks, with molecular weights of 8650.7 and 8646.3 Da, closely matched virtual fragments with calculated masses of 8651 Da for cleavage between S913 (P1) and R914 (P1’) and 8647 Da for cleavage between L912 (P1) and S913 (P1’). NMR models revealed these potential cleavage sites were solvent-exposed. To disrupt NE recognition, several gC1q domain mutants were generated at R914 and S913. Their proper folding was verified through solubility and thermostability assays before undergoing NE digestion.

Complement-related Services and Products

  1. Complement Products
  2. Complement Test Services

Creative Biolabs is one of the leading providers in the United States, providing pharmaceutical, bioscience, and contract research organizations with flexible and professional contract development of high-quality services and products. We have been selected by large pharmaceutical and biotech customers, and in every collaboration, we will apply our innovative spirit, deep expertise, abundant resources, and unparalleled support to create the best products and services for our fellow scientists. If you would like more details about our products and services, please feel free to contact us.

Reference

  1. Maiorani, Orlando, et al. "Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity." Scientific Reports 7.1 (2017): 39974. Distributed under Open Access license CC BY 4.0, without modification.
For Research Use Only.
Support

Online Inquiry